SUNPHARMA — Sun Pharmaceutical Industries Share News
0.000.00%
- IN₹4.51tn
- IN₹4.19tn
- IN₹584.62bn
Brief: Sun Pharma Approves Issuance Of NCDs Worth Up To 100 Billion Rupees
Brief: Sun Pharma To Consider Issuance Of NCDs Up To 150 Billion Rupees
India's Sun Pharmaceuticals to consider raising $1.55 billion via debentures
India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say
India's Sun Pharma new cholesterol drug deal to boost revenue, say brokerages
Advisory: Alert incorrectly tagged to Sun Pharma Advanced Research withdrawn
Brief: Sun Pharma Announces Global Licensing Agreement For Lerodalcibep Ex-Us And China
Tata bears marks of quasi-nationalisation
Tata bears marks of quasi-nationalisation
Brief: Sun Pharma Says Execution Of Settlement Agreement With A Plaintiff In The In Re Generic Pharmaceuticals Pricing Antitrust Litigation
Brief: S&P Says Sun Pharmaceutical Industries Assigned Preliminary 'BBB+' Rating With Stable Outlook
Brief: Moody's Ratings Assigns Baa1 Long-Term Issuer Rating To Sun Pharmaceutical Industries
Street View: India's Sun Pharma rises after U.S. tariff reprieve tied to drug-pricing deal
Brief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Brief: Sun Pharma Will Extend Most Favored Nation Pricing To U.S. Medicaid Programs
Trump administration announces drug pricing deals with CSL, Astellas and others (updated)
Brief: Sun Pharma Says U.S. Court Affirms Summary Judgment In Favor Of Sun Pharmaceutical In Lipitor Antitrust Litigation